Sign in
4

Changes in Ownership

Armata Pharmaceuticals, Inc. Filed Acc 0001209191-16-092454

Options or other derivatives

  • Chief Financial Officer acquired 99,919 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Martin Steven Robert Chief Financial Officer 2016-01-18 Grant or award · Stock Option (Right to Buy) +99,919 99,919 D: show line 1 in the form
Loading xslF345X03/doc4.xml…